Mo.Ma Ultra
Payments companies reported to CMS as associated with Mo.Ma Ultra. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mo.Ma Ultra, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mo.Ma Ultra
These are the largest totals companies reported as associated with Mo.Ma Ultra. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Siva Ketha | Raleigh, NC | Interventional Cardiology | $9,800.00 |
| Mathew Wooster | West Columbia, SC | Vascular Surgery | $5,400.00 |
| Michael Rosenberg | Minneapolis, MN | Vascular & Interventional Radiology | $3,250.00 |
| William Gray | Wynnewood, PA | Interventional Cardiology | $3,014.28 |
| David Stewart | Chicago, IL | Interventional Cardiology | $2,896.58 |
| Jacqueline Majors | Southaven, MS | Vascular Surgery | $2,443.14 |
| Ramesh Grandhi | Salt Lake City, UT | Neurological Surgery | $2,152.06 |
| Eric Scott | West Des Moines, IA | Vascular Surgery | $2,021.34 |
| Mark Koenig | Nashville, TN | Interventional Cardiology | $1,985.54 |
| Adnan Siddiqui | Williamsville, NY | Neurological Surgery | $1,900.00 |
Prescribed Mo.Ma Ultra?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.